ACUTA CAPITAL PARTNERS, LLC

Holdings History for Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Symbol: TRML
Investment type: Equity / Common stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-13%	$0	0	-268,451	-100%	$47.98	Q4 2025
30 Sep 2025	13%	-0.75%	$12,840,011	268,451	-15,231	-5.4%	$47.83	Q3 2025
30 Jun 2025	6.3%	-3.2%	$4,536,075	283,682	-143,200	-34%	$15.99	Q2 2025
31 Mar 2025	7.5%	+1.3%	$6,492,875	426,882	+75,040		$15.21	Q1 2025
31 Dec 2024	7.2%	+0.4%	$7,135,356	351,842	+19,747	+5.9%	$20.28	Q4 2024
30 Sep 2024	6.9%	+1.3%	$8,538,162	332,095	+62,481	+23%	$25.71	Q3 2024
30 Jun 2024	2.9%	+0.07%	$3,467,236	269,614	+8,506	+3.3%	$12.86	Q2 2024
31 Mar 2024	3.9%	+0.43%	$5,979,373	261,108	+29,226	+13%	$22.90	Q1 2024
31 Dec 2023	3.4%	+3.4%	$6,070,671	231,882	+231,882	NEW	$26.18	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.